<DOC>
	<DOCNO>NCT01017133</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , positron emission tomography , use drug fluorine F18-EF5 find oxygen fludeoxyglucose F18 find sugar tumor cell may help plan treatment patient non-small cell lung cancer .</brief_summary>
	<brief_title>Fluorine F18-EF5 Fludeoxyglucose F18 Positron Emission Tomography Assessing Hypoxia Glycolysis Patients With Stage I , Stage II , Stage III Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>PURPOSE : This clinical trial study fluorine F18-EF5 fludeoxyglucose F18 positron emission tomography assess hypoxia glycolysis patient stage I , stage II , stage III non-small cell lung cancer.Detailed DescriptionOBJECTIVES : I . To determine whether association Akt activation hypoxia determine 18F-EF5 PET scan patient NSCLC . II . To determine whether association Akt activation increase glycolysis determine 18F-FDG PET imaging patient NSCLC . OUTLINE : Within 6 week prior surgery , patient undergo fluorine F18 ( 18F ) -EF5 PET 10 minute 90 minute injection 18F-EF5 . Patients also undergo fludeoxyglucose F18 ( 18F-FDG ) PET 1 hour 3 hour injection 18FFDG . After completion study treatment , patient follow periodically 5 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>Subjects must histologically confirm NSCLC clinical image evidence de novo mass likely NSCLC , stage I , II , IIIA , surgery would indicate routine medical indication ECOG performance status 0 2 Subjects must sign informed consent document indicate aware investigational nature treatment protocol well potential risk benefit WBC &gt; 2,000/mm^3 Platelet count &gt; 100,000/mm^3 Total bilirubin Serum AST ALT Serum creatinine Negative serum pregnancy test female childbearing age History allergic reaction attribute Flagyl ( metronidazole ) , chemical structure similar EF5 Uncontrolled intercurrent illness would limit compliance study requirement Pregnant woman woman breastfeed excluded Subjects treat neoadjuvant radiation chemotherapy prior biopsy excision exclude impact therapy upon degree hypoxia tumor unknown</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>